REBECCA MICHAEL: Open Payments
NPI 1336808534 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$987 in 40 payments from 24 companies in 2025. Trend: 2023 $22 · 2024 $965 · 2025 $987
Food & beverage: $987
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $122 |
| Geron Corporation | 1 | $113 |
| Daiichi Sankyo Inc. | 4 | $96 |
| Novartis Pharmaceuticals Corporation | 3 | $72 |
| PFIZER INC. | 3 | $66 |
| Lilly USA, LLC | 2 | $49 |
| Incyte Corporation | 3 | $46 |
| Exelixis Inc. | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| EMD Serono, Inc. | 2 | $35 |
Products named: OJJAARA, RYTELO, Enhertu, KISQALI, XTANDI, VERZENIO, JAKAFI, CABOMETYX.
Industry payments across PA — which companies pay providers there.
